Powder: -20°C for 3 years | In solvent: -80°C for 1 year
EGFR-IN-451 is an EGFR inhibitor, attenuating Ang II-induced Kidney Fibrosis.
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
25 mg | 約6-8 週間 | ¥ 349,000 |
50 mg | 約6-8 週間 | ¥ 454,500 |
100 mg | 約6-8 週間 | ¥ 574,000 |
説明 | EGFR-IN-451 is an EGFR inhibitor, attenuating Ang II-induced Kidney Fibrosis. |
分子量 | 329.36 |
分子式 | C19H15N5O |
CAS No. | 220576-72-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
EGFR-IN-451 220576-72-7 BSF201640 BSF 201640 EGFR-IN451 DAT201 A-37203 BSF-201640 DAT 201 A 437203 Lu-201640 EGFR-IN 451 Lu 201640 ABT 925 ABT925 A-437203 Lu201640 DAT-201 ABT-925 A37203 A437203 Inhibitor inhibitor inhibit